Aptinyx Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder by Seini Moimoi | Oct 19, 2020 | Portfolio News
Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe by Seini Moimoi | Oct 16, 2020 | Portfolio News
Eargo, Inc. Announces Upsized Pricing of Initial Public Offering by Seini Moimoi | Oct 15, 2020 | Portfolio News
Epirium Bio Appoints Alexander Casdin, Reneo Capital Management Founder, as Chief Financial Officer Sandy Mahatme, Former Sarepta Therapeutics Chief Financial Officer and Chief Business Officer, Joins Board of Directors by Seini Moimoi | Oct 13, 2020 | Portfolio News
Nestlé announces results of tender offer for Aimmune Therapeutics, Inc. by Seini Moimoi | Oct 13, 2020 | Portfolio News
